156 related articles for article (PubMed ID: 11905647)
1. Breast cancer studies challenge tamoxifen therapy.
Timms B
Lancet Oncol; 2000 Nov; 1():132. PubMed ID: 11905647
[No Abstract] [Full Text] [Related]
2. Letrozole after tamoxifen for breast cancer--what is the price of success?
Bryant J; Wolmark N
N Engl J Med; 2003 Nov; 349(19):1855-7. PubMed ID: 14551339
[No Abstract] [Full Text] [Related]
3. Anti-tumor effects of letrozole.
Miller WR; Anderson TJ; Dixon JM
Cancer Invest; 2002; 20 Suppl 2():15-21. PubMed ID: 12442345
[TBL] [Abstract][Full Text] [Related]
4. Letrozole in breast cancer.
Shahab N
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971058
[No Abstract] [Full Text] [Related]
5. Letrozole in breast cancer.
Harris SR
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971059
[No Abstract] [Full Text] [Related]
6. Pre-operative endocrine therapy for postmenopausal women: when and why?
Tondini C; Fenaroli P; Labianca R
Ann Oncol; 2001 Nov; 12(11):1505-6. PubMed ID: 11822746
[No Abstract] [Full Text] [Related]
7. Aromatase inhibitors and inactivators in breast cancer.
Lønning PE
BMJ; 2001 Oct; 323(7318):880-1. PubMed ID: 11668120
[No Abstract] [Full Text] [Related]
8. Critics question price of success in halted clinical trial of aromatase inhibitor letrozole.
Twombly R
J Natl Cancer Inst; 2003 Dec; 95(23):1738-9. PubMed ID: 14652229
[No Abstract] [Full Text] [Related]
9. Aromatase inhibitors continue their ATAC on tamoxifen.
Nicholls H
Trends Mol Med; 2002; 8(4 Suppl):S12-3. PubMed ID: 11927281
[No Abstract] [Full Text] [Related]
10. [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].
Illiger HJ
Strahlenther Onkol; 2002 Feb; 178(2):111-3. PubMed ID: 11942036
[No Abstract] [Full Text] [Related]
11. Beyond tamoxifen--extending endocrine treatment for early-stage breast cancer.
Burstein HJ
N Engl J Med; 2003 Nov; 349(19):1857-9. PubMed ID: 14551340
[No Abstract] [Full Text] [Related]
12. Benefit of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
DeGrendele H
Clin Breast Cancer; 2003 Dec; 4(5):311-2. PubMed ID: 14715105
[No Abstract] [Full Text] [Related]
13. Superior efficacy of letrozole versus tamoxifen as first-line therapy.
Buzdar AU
J Clin Oncol; 2002 Feb; 20(3):876-8. PubMed ID: 11821477
[No Abstract] [Full Text] [Related]
14. Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.
Piccart MJ; Cardoso F; Atalay G
Eur J Cancer; 2002 Nov; 38 Suppl 6():S52-4. PubMed ID: 12409074
[No Abstract] [Full Text] [Related]
15. Emerging role of aromatase inhibitors in the adjuvant setting.
Goss PE
Am J Clin Oncol; 2003 Aug; 26(4):S27-33. PubMed ID: 12902874
[TBL] [Abstract][Full Text] [Related]
16. [Endocrine therapy of causation: role of aromatase inhibitors in breast cancer].
Longo F; Mansueto G
Tumori; 2003; 89(6):21-8. PubMed ID: 14870836
[No Abstract] [Full Text] [Related]
17. Drugs may improve long-term outcomes after breast cancer.
Mayo Clin Health Lett; 2004 Mar; 22(3):4. PubMed ID: 15000065
[No Abstract] [Full Text] [Related]
18. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
[TBL] [Abstract][Full Text] [Related]
19. Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy.
Smith IE
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):289-93. PubMed ID: 14623523
[TBL] [Abstract][Full Text] [Related]
20. Does letrozole have any place in adjuvant setting in breast cancer patients with documented hypercoagulability?
Oyan B; Altundag K; Ozisik Y
Am J Clin Oncol; 2004 Apr; 27(2):210-1. PubMed ID: 15057163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
